# EDGAR Filing Document

**Accession Number:** 0000720154
**File Stem:** 0001062993-23-001176
**Filing Date:** 2023-1
**Character Count:** 7194
**Document Hash:** 04894612393d50d34a08f1e450d465e0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-001176.hdr.sgml**: 20230120

**ACCESSION NUMBER**: 0001062993-23-001176

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230117

**FILED AS OF DATE**: 20230120

**DATE AS OF CHANGE**: 20230120

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Krupp Jeffrey Arthur
- **CENTRAL INDEX KEY:** 0001961914

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-23357
- **FILM NUMBER:** 23541024

**MAIL ADDRESS:**
- **STREET 1:** 2701 KENT AVENUE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Inotiv, Inc.
- **CENTRAL INDEX KEY:** 0000720154
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **IRS NUMBER:** 351345024
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 2701 KENT AVE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382
- **BUSINESS PHONE:** 3174634527

**MAIL ADDRESS:**
- **STREET 1:** 2701 KENT AVENUE
- **CITY:** WEST LAFAYETTE
- **STATE:** IN
- **ZIP:** 47906-1382

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIOANALYTICAL SYSTEMS INC
- **DATE OF NAME CHANGE:** 19970918

## Ex-24

```

POWER OF ATTORNEY

For Executing Forms 3, 4, 5 and 144

       The undersigned hereby constitutes and
appoints each of Nicole McDaniel, Beth Taylor,
and Fernanda Beraldi, signing singly, as the
undersigned's true and lawful attorney-in-fact,
for such period of time
that the undersigned is required to file reports
pursuant to Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange
Act"), or Rule 144 of the Securities Act of 1933,
as amended (the "Securities Act"), due to his
affiliation with Inotiv, Inc., an Indiana corporation,
unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing
attorneys-in-fact, to:

1) execute for and on behalf of the undersigned Form
ID, Forms 3, 4, 5 and 144 and any amendments
to previously filed forms in accordance
with Section 16(a) of the Exchange Act or
Rule 144 of the Securities Act and
the rules thereunder;

2) do and perform any and all acts for and on
behalf of the undersigned which may be
necessary or desirable to complete the execution
of any such Form ID, Forms 3, 4, 5 and 144
and the timely filing of such form with
the United States Securities and Exchange
Commission and any other authority as required
by law; and

3) take any other action of any type whatsoever
in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be
of benefit to, in the best interest of
or legally required by the undersigned,
it being understood that the documents executed
by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such
terms and conditions as such attorney-in-fact
may approve in his discretion.

       The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform all and every act and thing whatsoever
requisite, necessary and proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes
as the undersigned could do if personally present,
with full power of substitution or
revocation, hereby ratifying and confirming
all that such attorney-in-fact, or his
substitute or substitutes, shall lawfully do
or cause to be done by virtue of this Power of
Attorney and the rights and powers herein
granted.  The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned,
are not assuming any of the undersigned's
responsibilities to comply with Section 16 of
the Exchange Act or Rule 144 of the Securities Act.

        IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of this
9th day of January, 2023.

/s/ Jeffrey Arthur Krupp
       Jeffrey Arthur Krupp

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Krupp Jeffrey Arthur<br><sub>(Last) (First) (Middle)</sub><br>2701 KENT AVENUE<br><sub>(Street)</sub><br>WEST LAFAYETTE, IN 47906-1382<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Inotiv, Inc. [ NOTV ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-17 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Human Resources Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 5000<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Represents restricted shares, which vest in full on March 28, 2024, subject to continued employment.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Beth Taylor, Attorney-in-Fact for Jeffrey A. Krupp  
**Date:** 2023-01-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**